日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Analgesic Efficacy of a Novel Traditional Chinese Medicine Ointment Against Mechanical Allodynia in Rat Models

一种新型中药软膏对大鼠机械性痛觉过敏的镇痛效果

Liu, Huan; Deng, Juan; Wei, Jiao; Wu, Juan; Gan, Yi; Hu, Yongqun; Mo, HongMei

Reinfection and Resistance Associated Substitutions Following a Minimal Monitoring Approach for Hepatitis C Virus Treatment in MINMON Trial

在 MINMON 试验中,采用最低限度监测方法治疗丙型肝炎病毒感染后,再感染和耐药性相关的替代情况

Han, Win Min; Solomon, Sunil Suhas; Smeaton, Laura; Avihingsanon, Anchalee; Wagner Cardoso, Sandra; Li, Jiani; Parvangada, Aiyappa; Sulkowski, Mark; Naggie, Susanna; Martin, Ross; Mo, Hongmei; Maiorova, Evguenia; Wyles, David

Rapid Transmission and Divergence of Vancomycin-Resistant Enterococcus faecium Sequence Type 80, China

中国耐万古霉素粪肠球菌80型序列的快速传播与分化

Li, Liqiang; Wang, Xingwei; Xiao, Yanyu; Fan, Bing; Wei, Jiehong; Zhou, Jie; Lai, Zetian; Zhang, Yanpeng; Mo, Hongmei; Zhang, Li; Luo, Dixian; Gu, Dayong; Yang, Shucai; Wang, Yidi; Qu, Jiuxin

Development and Implementation of an Internal Quality Control and External Quality Assessment Information System for a Regional Medical Laboratory Center: Pilot Design and Implementation Study

区域医学检验中心内部质量控制和外部质量评估信息系统的开发与实施:试点设计与实施研究

Chen, Dayang; Mo, Hongmei; Zhang, Yingying; Qin, Junlong; Zhang, Lijun; Jiang, Changxian; Li, Fuming; Zhang, Xiuming; Ou, Tong

Severe Plasmodium Falciparum Malaria Mimicking Thrombotic Thrombocytopenic Purpura (TTP): A Case Report From China

中国一例重症恶性疟原虫疟疾酷似血栓性血小板减少性紫癜(TTP)的病例报告

Wang, Cheng; Kong, Man; Huang, Ming; Tang, Ning; Mo, Hongmei

The effects of postoperative targeted immunotherapy on peripheral blood cytokines and immune cell profile in lung cancer patients

术后靶向免疫治疗对肺癌患者外周血细胞因子和免疫细胞谱的影响

Zhang, Chuang; Mo, Hongmei; Li, Min; Wang, Shuaiyan; Dou, Xiaowen; Zhang, Xiuming

Correction for Han et al., "In Vitro Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor Voxilaprevir"

对 Han 等人的论文“丙型肝炎病毒基因型 1 至 6 临床分离株对泛基因型 NS3/4A 抑制剂 Voxilaprevir 的体外敏感性”的更正

Han, Bin; Parhy, Bandita; Lu, Julia; Zhou, Eric; Hsieh, David; Camus, Gregory; Martin, Ross; Svarovskaia, Evguenia S; Mo, Hongmei; Dvory-Sobol, Hadas

Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients

开发一种预测膀胱癌患者总体生存率的新型预后特征

Tang, Huamei; Kan, Lijuan; Ou, Tong; Chen, Dayang; Dou, Xiaowen; Wu, Wei; Ji, Xiang; Wang, Mengmeng; Zong, Zengyan; Mo, Hongmei; Zhang, Xiuming; Xiong, Dan

Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes

丙型肝炎病毒对干扰素λ多态性的适应性在多种病毒基因型中

Chaturvedi, Nimisha; Svarovskaia, Evguenia S; Mo, Hongmei; Osinusi, Anu O; Brainard, Diana M; Subramanian, G Mani; McHutchison, John G; Zeuzem, Stefan; Fellay, Jacques

In Vitro Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor Voxilaprevir

丙型肝炎病毒基因型 1 至 6 临床分离株对泛基因型 NS3/4A 抑制剂伏西瑞韦的体外敏感性

Han, Bin; Parhy, Bandita; Lu, Julia; Hsieh, David; Camus, Gregory; Martin, Ross; Svarovskaia, Evguenia S; Mo, Hongmei; Dvory-Sobol, Hadas